Natural Alternatives International, Inc.: stock overview

NAIINASDAQBasic materials · Medicinal Chemicals & Botanical Products

Price

$0.97

November 13, 2026Market cap $5.8M

What Ploutos Investor adds for Natural Alternatives International

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from FY2011
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 43% since Sep 28, 2026, when the 10-K these figures come from was filed ($1.70 then, $0.97 on Nov 13, 2026). The figures date from before that move.10-K

In short

Natural Alternatives International had revenue of $133M over the last 12 months and a net loss of $23M. Revenue fell by 4.4% a year on average over the last 5 years. It has net debt of $4.3M. It pays no dividend.

From its SEC filings (latest fiscal year to June 30, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$5.8M
6.03M shares
P/E
–
Revenue, 12 months
$133M
-4.4% a year over 5 years
Net margin
-17.2%
FY2025: -10.5%, above 40% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+11.9% a year over 2 years

  • FY2026Jun 30, 202610-K
    Revenue$143M
  • FY2025Jun 30, 202510-K
    Revenue$130M
  • FY2024Jun 30, 202410-K
    Revenue$114M

Fiscal years in figures

NAII's revenue, profit, cash flow and dividend with each year-end price, from FY2011 to FY2023, 13 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $20M
$5.8M
Enterprise value 
$10M
P/E 
–
EV / EBIT 
–
EV / Revenue 
0.1
P/B 3-year median: 0.3
0.1
FCF yield 3-year median: -12.1%
–
Earnings yield 3-year median: -69.5%
–

Profitability

Gross margin 
4.4%
Operating margin 
-16.3%
Net margin 3-year median: -10.5%
-17.2%
ROIC 
-25.9%
ROIC, 5-year average 
-5.1%
ROE 
-41.0%

Growth

Revenue, yearly change 
+9.8%
EPS, yearly change 
–
FCF, yearly change 
-644.3%
Revenue, average a year 
-4.4%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$6.5M
Total debt 
$41M
Of which operating leases 
$30M
Net debt 
$4.3M
Net debt / EBITDA 
–
Interest cover 
–
Current ratio 
1.37

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
1.53%
Total returned 
1.53%
Shares, yearly change 
-2.3%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 28).

Gross margin

7.1%

Above 6% of the 141 companies in its industry, and 7% of all.

Operating margin

-6.7%

Above 46% of the 285 companies in its industry, and 23% of all.

Net margin

-10.5%

Above 40% of the 302 companies in its industry, and 18% of all.

ROE

-27.2%

Above 29% of the 267 companies in its industry, and 12% of all.

ROA

-10.7%

Above 34% of the 313 companies in its industry, and 14% of all.

Revenue growth

14.1%

Above 64% of the 292 companies in its industry, and 72% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
NATURAL ALTERNATIVES INTERNATIONAL INC
Exchange
NASDAQ
Industry (SIC)
2833 · Medicinal Chemicals & Botanical Products
Fiscal year ends
June 30
Latest annual report
June 30, 2026
Reporting currency
USD
Shares
6.03M

Other companies: Basic materials

The largest companies of the same sector, each with its own page.

The Basic materials sectorAll companies

The full analysis

What do Natural Alternatives International's filings show?

These are Natural Alternatives International's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NAII

Didn't find what you were looking for?

Ask us
What is NAII's market cap?

Natural Alternatives International, Inc.'s market cap is $5.8M, at a price of $0.97 on November 13, 2026 and 6.03M shares.

How much revenue does NAII have?

Natural Alternatives International had revenue of $133M over the last 12 months. Over the last 5 years it changed by -4.4% a year on average.

Does NAII pay a dividend?

No. Natural Alternatives International paid no regular dividend over the last 12 months.

Where do the figures come from?

From Natural Alternatives International, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.